Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1219956-23-6 | 2,4-Diphenyl-6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,5-triazine | AA00A04O | MFCD29918901
1260798-14-8 | 7-Fluoro-imidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester | AA00A0LO | MFCD11976204
1246094-78-9 | AZD 7762 hydrochloride | AA00A15R | MFCD12546135
1220037-14-8 | 2-Amino-N-(tert-butyl)-2-methylpropanamide hydrochloride | AA00A2BF | MFCD13562441
131580-51-3 | 1-(2-Bromopropanoyl)azepane | AA00A4JP | MFCD10703563
127958-17-2 | 4-(Methoxymethyl)pyrimidin-2-amine | AA00A78M | MFCD18816602
1221347-27-8 | 1-Boc-2,3-dihydro-[1,4]oxazine | AA00A9YN | MFCD16039461
19407-54-6 | 8-Chloro-2-methyl-4-quinazolone | AA00AAWD | MFCD09800989
198879-38-8 | 2-([(4-Fluorophenyl)amino]methyl)phenol | AA00AB4Y | MFCD00020058
163768-50-1 | Auristatin F | AA00ABFW | MFCD25976745